6407 — CKD Income Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousMid CapSuper Stock

Annual income statement for CKD, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	106,723	142,199	159,457	134,425	155,634
Cost of Revenue
Gross Profit	28,773	40,891	46,398	38,042	45,200
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	99,092	124,526	138,405	121,540	136,433
Operating Profit	7,631	17,673	21,052	12,885	19,201
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7,727	17,947	21,388	12,904	19,588
Provision for Income Taxes
Net Income After Taxes	5,282	12,600	14,789	8,338	13,520
Minority Interest
Net Income Before Extraordinary Items
Net Income	5,274	12,568	14,789	8,338	13,520
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,273	12,567	14,788	8,338	13,520
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	80.9	191	223	127	201
Dividends per Share